First National Bank of Omaha Takes Position in The Clorox Company $CLX

First National Bank of Omaha purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,900 shares of the company’s stock, valued at approximately $604,000.

Other large investors have also recently made changes to their positions in the company. Nomura Asset Management Co. Ltd. boosted its stake in shares of Clorox by 9.0% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after purchasing an additional 27,639 shares during the period. Hudson Bay Capital Management LP purchased a new stake in shares of Clorox in the second quarter worth approximately $8,568,000. Vise Technologies Inc. bought a new stake in shares of Clorox during the 2nd quarter worth approximately $328,000. Vanguard Personalized Indexing Management LLC boosted its holdings in Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after acquiring an additional 10,065 shares during the period. Finally, ProShare Advisors LLC grew its position in Clorox by 11.7% in the 3rd quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock valued at $159,922,000 after acquiring an additional 136,135 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. The Goldman Sachs Group cut their price target on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a report on Wednesday, January 7th. Royal Bank Of Canada set a $132.00 price target on shares of Clorox in a report on Wednesday, February 4th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Clorox from $114.00 to $112.00 and set a “hold” rating for the company in a research note on Wednesday, February 4th. Rothschild & Co Redburn set a $117.00 target price on Clorox in a research report on Friday, February 13th. Finally, Evercore reduced their price target on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research report on Wednesday, February 4th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $118.73.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox published a consumer research report, “Home Care Redefined,” highlighting shifting demand toward wellness‑focused and convenience‑oriented home care — a narrative that supports Clorox’s premium, innovation and marketing strategies and could help sustain pricing/brand strength. Home Care Redefined
• Neutral Sentiment: Management presented prepared remarks at the Consumer Analyst Group of New York (CAGNY) conference; these presentations typically reiterate strategy and portfolio priorities but rarely change near‑term financials unless new guidance is provided. Investors will be watching for Q&A takeaways on cost savings, innovation cadence and margin recovery. CAGNY Prepared Remarks Transcript
• Neutral Sentiment: Wells Fargo reiterated a Hold on CLX (coverage note flagged in recent press), which is unlikely to trigger strong buying momentum; it keeps analyst sentiment around the stock cautious. Wells Fargo Hold
• Negative Sentiment: Zacks Research cut multiple near‑term EPS estimates (several quarters and FY2027 modestly lowered) and kept a “Hold” rating. The downward revisions signal weaker near‑term profit expectations and are the most direct driver of selling pressure today. (Source: Zacks research notes summarized across recent releases.)

Clorox Price Performance

NYSE CLX opened at $122.04 on Friday. The company has a market cap of $14.76 billion, a price-to-earnings ratio of 19.94, a PEG ratio of 0.61 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The stock’s fifty day moving average price is $109.36 and its 200 day moving average price is $113.68. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $159.04.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company posted $1.55 earnings per share. The firm’s revenue for the quarter was down .8% on a year-over-year basis. As a group, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.